In a significant shake-up, CBS News CEO Wendy McMahon has resigned following increasing pressure from Paramount Global's leadership. This decision comes amidst controversies surrounding the journalistic independence of CBS's flagship program, '60 Minutes.'
Epic Games is fighting back against Apple in a legal battle to reinstate Fortnite on the iOS App Store. After a recent court ruling, the company claims Apple's rejection is retaliation for its legal actions.
Intel showcases its new Arc Pro B-Series graphics cards, featuring significant improvements for AI workloads and enhanced Linux support, set to launch in Q3. Discover the specs and pricing!
Microsoft takes a significant leap forward by launching the Model Context Protocol (MCP) in Windows, enabling AI agents to interact seamlessly with applications and services. This innovation aims to reshape how users engage with technology, but security risks loom.
In a surprising announcement, former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has spread to his bones. Despite the severity, experts suggest effective treatment options are available, offering hope for his recovery.
Episode 6 of 'The Last of Us' reveals the emotional turmoil between Joel and Ellie during her birthdays. Tensions rise as past lies come to light, reshaping their relationship forever.
In a controversial move, the Supreme Court has permitted the Trump administration to revoke legal protections for over 300,000 Venezuelan immigrants, potentially leading to mass deportations. This decision reverses a Biden-era policy aimed at providing humanitarian relief amidst Venezuela's ongoing instability.
Sesame Street is moving to Netflix with a reimagined 56th season featuring new 11-minute stories and returning favorites like Elmo’s World. Plus, 90 hours of classic episodes will be available worldwide!
In a heartfelt message, former President Joe Biden announced his aggressive prostate cancer diagnosis, thanking Americans for their support while emphasizing the importance of hope and resilience in the face of adversity.
In a surprising turn of events, Regeneron has announced its acquisition of 23andMe for $256 million following the company's bankruptcy. The pharma giant aims to leverage 23andMe's vast customer data for drug discovery while prioritizing privacy and security.
